A new clinical trial showed promising results in curbing alcohol cravings in individuals with moderate alcohol-use disorder.

More and more Americans are turning to GLP-1 injections to lose weight. FOX 7 Austin's Rebecca Thomas spoke to an Austin ...

Scientists have discovered an antibody treatment that may help prevent both muscle loss and bone density loss in people using ...

As demand remains high for GLP-1 drugs, primary care physicians are concerned about the risks of patients using third-party ...

A human-derived, ultra-long-acting GLP-1 injection independently researched and developed by Innogen, a Shanghai-based ...

They also discovered that cigarette use declined among a subgroup of smokers in the study, lending weight to the hypothesis ...

The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients.

美国食品药品管理局（FDA）批准了首个仿制药Victoza（利拉鲁肽注射液）18毫克/3毫升，这是一种胰高血糖素样肽-1（GLP-1）受体激动剂，用于作为饮食和运动的辅助手段改善成人和10岁及以上儿童2型糖尿病患者的血糖控制。

Telehealth company Hims & Hers Health Inc. (NYSE: HIMS) was already a thriving platform discretely selling doctor-prescribed sexual health treatment along with prescription hair loss and mental ...

Liraglutide, a GLP-1 significantly lowers the rate of recurrent stroke in patients with diabetes, with no apparent increase ...

However, the company supercharged its top and bottom line with the addition of compounded semaglutide GLP-1 injections that start at $99 the first month and go up to $199 afterward. Compounded GLP ...